Diagnostic Enzymes Market Estimated To Flourish By 2030: Grand View Research Inc.

 Diagnostic Enzymes Market Growth & Trends

The global diagnostic enzymes market size is expected to reach USD 6.27 billion by 2030, registering a CAGR of 5.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Request a free sample copy or view the report summary: Diagnostic Enzymes Market Report

Diagnostic Enzymes Market Report Highlights

• In 2023, the glucose oxidase/glucose dehydrogenase enzyme segment held a dominant share in the market owing to the presence of an abundance of enzymesin living organisms
• The oncology segment is projected to grow at the fastest rate during the forecast period owing to the increasing prevalence of cancer among the population
• The clinical segment is the highest revenue-generating segment in 2023 owing to the increased focus on R&D
• The diagnostic enzyme market is witnessing change owing to the presence of key market players focusing on product launches and geographic expansion to maintain their position in the market
• Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the presence of the target population

Access Press Release@ https://www.grandviewresearch.com/press-release/global-diagnostic-enzymes-market

Diagnostic Enzymes Market Segmentation

Grand View Research has segmented the global diagnostic enzymes market report based on type, application, product, and region:

Diagnostic Enzymes Type Outlook (Revenue, USD Million, 2018 - 2030)

• Taq Polymerase
• MMLV RT
• HIV RT
• Hot Start Taq Polymerase
• UNG
• RNase Inhibitors
• Bst Polymerase
• PCR Master Mix
• Lyophilized Polymerase
• T7 RNA Polymerase
• Cas9 Enzyme
• Acid Phosphatase
• Alanine Aminotransferase
• Alkaline phosphatase
• Amylase
• Angiotensin Converting Enzyme
• Aspartate Aminotransferase
• Cholinesterase
• Creatinine Kinase
• Gamma Glutamyl Transferase
• Lactate Dehydrogenase
• Renin
• Glucose Oxidase/Glucose Dehydrogenase
• Urease
• Lactate Oxidase
• Horseradish Peroxide
• Glutamate Oxidase
• Others

Diagnostic Enzymes Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetes
• Oncology
• Cardiology
• Infectious Diseases
• Nephrology
• Autoimmune Diseases
• Others

Diagnostic Enzymes Product Outlook (Revenue, USD Million, 2018 - 2030)

• Molecular Enzymes
• Clinical Enzymes

Diagnostic Enzymes End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Clinical Laboratories
• Other End Users

Diagnostic Enzymes Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Diagnostic Enzymes Market

• Takara Bio, Inc.
• Promega Corporation
• Enzo Life Sciences, Inc.
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Creative Enzyme
• Hoffmann-La Roche Ltd.
• Solis BioDyne.
• Ambliqon A/S.
• Yashraj Biotechnology Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Amines Market Latest Trends, Industry Growth And Forecast To 2030: Grand View Research Inc.

 Amines Market Growth & Trends

The global amines market size is anticipated to reach USD 30.74 billion by 2030 and is projected to expand at a CAGR of 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is majorly attributed to surging demand for the product as a surfactant and also for utilization in agricultural crop protection chemicals. The growing need for food security due to the increasing global population is expected to drive the market for crop protection chemicals, which, in turn, drives the market growth for the product.

Ethanolamine, in the form of triethanolamine and monoethanolamine, is mainly used as a cleaning agent. It is also used as a corrosion inhibitor in machining fluids, lubricants, and cooling systems for automotive, industrial, and marine applications. Rising health awareness and an inclination toward preventive maintenance are expected to propel demand for ethanolamine as a cleaning agent and corrosion inhibitor.

The product is used in gas treatment, which takes into consideration amine gas treatment, which uses an aqueous solution of different amines to dissolve and remove hydrogen sulfide and carbon dioxide from the refinery.

Natural gas, when extracted from its primary sources, typically has numerous undesirable compounds mixed in it, thus making the gas unusable for a multitude of application areas. These compounds majorly include hydrogen sulfide (H2S) and carbon dioxide (CO2). Amines are used in the treatment of natural gas to remove such impurities/undesirable products. Some of the commonly used products in the process of gas treatment include monoethanolamine (MEA), diethanolamine (DEA), and methyl diethanolamine (MDEA), among others.

Numerous technologies have been introduced in the market concerning amines. For instance, Croda Polymers & Coatings introduced novel technologies to develop bio-based amine-functional building blocks for use in coatings and adhesives. Further, BASF announced the building of a production plant for specialty amines in Nanjing Chemical Park, China, which was commercialized for production by late 2015.

Raw materials and energy are the two most significant elements in the cost structure of the product manufacturing process. On average, raw materials constitute 22% of the cost structure in amines production, closely followed by energy, which accounts for 21%. Labor and overhead costs constitute 16% and 13%, respectively. Other costs include transport, distribution, and depreciation, accounting for 28%.

The market is highly fragmented owing to the presence of numerous local and global players. Key companies operating in this market are BASF SE, AkzoNobel, The Dow Chemicals Company, Clariant, etc.

Request a free sample copy or view report summary: Amines Market Report

Amines Market Report Highlights

• Ethanolamine dominated the market with a revenue share of 52.2% in 2023 owing to its numerous applications, such as surfactants, corrosion inhibitors, textile processing, gas treatment, and personal care products.
• Surfactants application dominated the market with a revenue share of 27.5% in 2023 owing to its widespread utilization across industries such as in personal care and household cleaning.
• Asia Pacific dominated the global market with a revenue share of 45.6% in 2023 owing to the rising public awareness regarding health and hygiene, in addition to the adoption of higher standards of cleaning and disinfection, which is expected to be the prime driver for cleaners or disinfecting formulations in the region.
• The North America market is expected to exhibit a rise in the demand for disinfectants over the forecast period owing to increasing awareness regarding personal hygiene in households post COVID-19.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-amines-market

Amines Market Segmentation

Grand View Research has segmented the global amines market based on product, application, and region:

Amines Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Ethanolamine
• Fatty Amines
• Alkyl Amines
• Others

Amines Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Crop Protection
• Surfactants
• Water Treatment
• Personal Care
• Gas Treatment
• Others

Amines Region Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players in the Amines Market

• Arkema S.A.
• Akzo Nobel N.V.
• BASF SE
• SABIC
• The Dow Chemical Company
• Huntsman Corporation
• Mitsubishi Gas Chemical Company
• Taminco Corporation
• Celanese Corporation
• Solvay S.A.
• INEOS Group
• Lanxess Corporation
• LyondellBasell Industries Holdings B.V.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Immuno-oncology Clinical Trials Market Expected to Succeed in CAGR of 12.1% by 2030

 Immuno-oncology Clinical Trials Market Growth & Trends

The global immuno-oncology clinical trials market size is expected to reach USD 18.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.1% from 2024 to 2030. The rapidly growing field of Immuno-oncology has emerged as a novel therapeutic area within the oncology ecosystem, transforming the treatment of cancer.

From 2014 to 2017, the number of new immuno-oncology studies increased from 250 to almost 600, with double-digit growth rates each year as drug classes diversified. Biomarker and checkpoint inhibitor studies were primarily responsible for this rapid growth. While the immuno-oncology market is maturing in some pharmacological classes, cell therapies are exceeding all other immunotherapeutics in terms of growth. In March 2020, there were 1,483 active compounds in the pipeline for cancer cell therapy globally, indicating an increase of 472 from March 2019. The fastest-growing category was chimeric antigen receptor T (CAR-T) cell products (up 77% from 2019 to 2020).

Besides, during the Covid-19 pandemic, the number of IO drugs in development increased from 3,876 in 2019 to 4,720 in 2020, representing a 22% & 233% increase as compared to 2019 & 2017 respectively. After a moderate increase of 15% in 2019 compared to 68% between 2018 and 2017, this 22% increase indicates a return of interest in IO, despite the impact of the COVID-19 pandemic.

Request a free sample copy or view report summary: Immuno-oncology Clinical Trials Market Report

Immuno-oncology Clinical Trials Market Report Highlights

• Phase III dominated the market with the largest share of 53.2% in 2023. Oncology trials typically have fewer participants, are the most expensive, and involve larger sample sizes, resulting in a higher cost per participant.
• The interventional experiments accounted for more than 78.5% of the market share in 2023
• The segment of solid tumors held 55.9% of the revenue share in 2023. This is largely attributed to the rise in the prevalence of solid tumors
• North America dominated the market and accounted for the largest revenue share of 50.3% in 2020. This is due to the rising adoption of personalized medicine-focused novel treatment methods, as well as the government funding and investments

Access Press Release@ https://www.grandviewresearch.com/press-release/global-immuno-oncology-clinical-trials-market

Immuno-oncology Clinical Trials Market Segmentation

Grand View Research has segmented the global immuno-oncology clinical trials market based on phase, design, indication, and region:

Immuno-oncology Clinical Trials Phase Outlook (Revenue, USD Billion, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

Immuno-oncology Clinical Trials Design Outlook (Revenue, USD Billion, 2018 - 2030)

• Interventional Trials
• Observational Trials
• Expanded Access Trials

Immuno-oncology Clinical Trials Indication Outlook (Revenue, USD Billion, 2018 - 2030)

• Solid Tumors
• Hematological Cancer

Immuno-oncology Clinical Trials Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Immuno-oncology Clinical Trials Market

• MEDPACE
• Novartis
• Exscientia
• Syneous Health
• AstraZeneca
• IQ BIOTECH
• BioNtech
• IQVIA Holdings
• ICON, Plc
• Covance, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Term Insurance Market 2024 Global Key Vendors Analysis, Revenue, Trends & Forecast to 2030

 Term Insurance Market Growth & Trends

The global term insurance market size is anticipated to reach USD 1,897.40 billion by 2030 and is anticipated to expand at a CAGR of 8.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing digital transformation in the insurance sector is expected to create growth opportunities for the market. Various factors, such as the growing disposable income of the population, the emergence of InsurTech, and the growing middle-class population in developing economies such as China, India, and Brazil, are propelling the demand for the term insurance.

The growing digitization of the insurance industry is driving prominent term insurance providers to launch digital solutions. For instance, in November 2023, Life Insurance Corporation of India launched a new Tech-Term Insurance Plan. The new Tech-Term insurance plan is a non-linked, pure protection, online, and without-profit term insurance plan. The plan is available through online processes only, and no intermediaries are involved. Such plans are driving the adoption of term insurance among consumers due to its easy access and hassle-free process, thus benefiting the market’s growth.

Term Insurance providers are adopting cutting-edge advanced technology to automate the insurance process, reduce operating costs, and improve efficiency. This technology includes machine learning for the automation of risky and complex processes and artificial intelligence such as blockchain, robotic process automation, and robot advisors for the automation of insurance. Such technologies are expected to improve the risk-return trade-off for both insurers and policyholders, thus harnessing the market’s growth over the forecast period.

However, the term insurance sector encounters notable challenges, such as low public awareness about the benefits, evolving regulatory requirements, complex underwriting processes, and the need for affordable yet comprehensive coverage. Market leaders are actively working to address these challenges, simplifying policies, improving customer education, and adapting to changing regulations to stimulate market growth.

Request a free sample copy or view report summary: Term Insurance Market Report

Term Insurance Market Report Highlights

• The individual-level term life insurance segment is expected to grow significantly over the forecast period. The increasing awareness of the importance of financial protection and the need for affordable coverage among individuals and families are driving the segment’s growth.
• The broker segment is expected to grow significantly over the forecast period. The ability of brokers to provide personalized, expert guidance to customers, helping them navigate the complex insurance landscape and select policies that best suit their needs, is driving the segment’s growth.
• North America is anticipated to register significant growth over the forecast period. The regional growth can be attributed to the rising adoption of cutting-edge advanced technology to automate the insurance process, reduce operating costs, and improve efficiency.
• In August 2023, The Savings Bank Mutual Life Insurance Company of Massachusetts announced the launch of its new solution, AcceleRate. This innovative offering assures distribution partners and customers of rapid processing, dependability, and convenience, coupled with competitive rates on a range of term and whole life insurance products. The launch marks a significant advancement in the company's commitment to providing efficient and value-driven solutions in the insurance market.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-term-insurance-market

Term Insurance Market Segmentation

Grand View Research has segmented the global term insurance market based on type, distribution channel, and region.

Term Insurance Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Individual Level Term Life Insurance
• Group Level Term Life Insurance
• Decreasing Term Life Insurance

Term Insurance Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2030)

• Tied Agents & Branches
• Brokers
• Others

Term Insurance Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
• Middle East & Africa
  • Kingdom of Saudi Arabia (KSA)
  • UAE
  • South Africa

List of Key Players in the Term Insurance Market

• MetLife Services and Solutions, LLC.
• Aegon Life Insurance Company Limited
• Prudential Financial, Inc.
• The Northwestern Mutual Life Insurance Company
• State Farm Mutual Automobile Insurance Company
• Massachusetts Mutual Life Insurance Company
• American International Group, Inc.
• Lincoln National Corporation
• John Hancock
• China Life Insurance (Overseas) Company Limited
• Bajaj Allianz Life Insurance Co. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sports Nutrition And Dietary Supplements Testing & Certification Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 Sports Nutrition And Dietary Supplements Testing & Certification Market Growth & Trends

The global sports nutrition and dietary supplements testing & certification market size is anticipated to reach USD 1,042.6 million by 2030 and is projected to grow at a CAGR of 13.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to experience growth due to factors such as the sale of counterfeit products, heightened health consciousness, increased awareness of sports nutrition and dietary supplements, and improved accessibility and availability of supplements.

Protein verification services are becoming an increasingly important type of testing procedure in the global market. These services include testing and verification of the amount of protein in a product to ensure that it matches the label claim. This is important for athletes and fitness enthusiasts who rely on protein supplements to build & repair muscles. However, with growing accessibility to supplements, the risk of product counterfeiting is also rising. Several cases of product counterfeiting and mislabeling have been observed in recent years, which has increased concerns about fake supplement products. For instance, in 2019, owners of Blackstone Labs were charged for selling dietary supplements containing various illegal constituents such as DMBA, SARMs, and dimethazine.

The charges alleged that the owners of Blackstone Labs were aware that their products were illegal and formed illicit companies to manufacture their products & then supply them through distributors. Moreover, several government agencies are also taking cognizance of the situation and taking action to seize the supply of fraudulent products.

The market has witnessed significant growth post-pandemic due to the increasing awareness among consumers regarding health and wellness. The market is driven by several factors, including the rising demand for safe & effective products, increasing stringency of regulations governing the quality of these products, and the growing trend of fitness & healthy lifestyle. Majority of the manufacturers operating in sports nutrition are emphasizing R&D activities to develop innovative products as per customer needs, thereby generating substantial growth opportunities. Thus, the increasing demand for sports nutrition products & dietary supplements and heightened focus on ensuring the safety and quality of these products post-pandemic are expected to drive the market growth in the near future.

The lack of safety and testing infrastructure for sports nutrition and dietary supplements in developing countries poses significant challenges. The availability of accredited laboratories for testing the safety and quality of sports nutrition products may be scarce in developing countries. This limitation hinders conducting thorough analyses and ensuring compliance with established standards. Developing countries may face a shortage of qualified professionals with expertise in assessing the safety and efficacy of dietary supplements. This hindrance in the growth of nutrition and supplements industry may further impede the growth of allied industries such as testing and certification services.

Request a free sample copy or view report summary: Sports Nutrition And Dietary Supplements Testing & Certification Market Report

Sports Nutrition And Dietary Supplements Testing & Certification Market Report Highlights

• Based on type, the analytical testing segment led the market with the largest revenue share of 41.02% in 2023, owing to technological advancements in analytical methods, such as High-Performance Liquid Chromatography (HPLC) and mass spectrometrythat enhance the precision and efficiency of these tests, making them essential for product development and quality assurance
• Based on ingredient, the amino acidsegment led the market with the largest revenue share of 25.46% in 2023. On the other hand, herbal segment is expected to grow at the fastest CAGR of 15.47% from 2024 to 2030
• Based on service provider, the testing laboratories & companies segment led the market with the largest revenue share of 70.22% in 2023. Furthermore, regulatory consulting companies are expected to grow at the fastest CAGR over the forecast period
• Based on end use, the manufacturers segment led the market with the largest revenue share of 48.92% in 2023, as manufacturers are leveraging technology to streamline the certification process and enhance transparency
• North America dominated the market with the largest revenue share of 39.69% in 2023, owing to factors such as heightened awareness regarding sports nutritional products & supplements, stringent government regulations, etc.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sports-nutrition-dietary-supplements-testing-certification-market

Sports Nutrition And Dietary Supplements Testing & Certification Market Segmentation

Grand View Research has segmented the global sports nutrition and dietary supplements testing & certification market based on type, ingredient, service provider, end-use, and region:

Sport Nutrition And Dietary Supplements Testing & Certification Type Outlook (Revenue, USD Million, 2018 - 2030)

• Stability Testing
• Analytical Testing
• Microbiological Testing
• Regulatory Testing & Compliance
• Others

Sport Nutrition And Dietary Supplements Testing & Certification Ingredient Outlook (Revenue, USD Million, 2018 - 2030)

• Herbal
• Vitamins
• Minerals
• Amino Acids
• Enzymes
• Probiotics
• Others

Sport Nutrition And Dietary Supplements Testing & Certification Service Provider Outlook (Revenue, USD Million, 2018 - 2030)

• Testing Laboratories & Companies
• Contract Research Organizations (CROs)
• Regulatory Consulting Companies
• Others

Sport Nutrition And Dietary Supplements Testing & Certification End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Manufacturers
• Contract Manufacturers
• Distributors
• Others

Sport Nutrition And Dietary Supplements Testing & Certification Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • New Zealand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Sports Nutrition And Dietary Supplements Testing & Certification Market

• NSF International
• Eurofins Scientific
• Intertek Group plc
• BSCG LLC
• UL LLC
• Canadian Analytical Laboratories Inc.
• TÜV SÜD
• SGS Société Générale de Surveillance SA (Nutrasource)
• LGC Limited
• com
• The United States Pharmacopeial Convention (USP)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Mining Chemicals Market Predicted to Cross $17.54 Billion by 2030: Grand View Research Inc.

 Mining Chemicals Market Growth & Trends

The global mining chemicals market size is expected to reach USD 17.54 billion by 2030 and expanding at a CAGR of 6.4% from 2024 to 2030, as per the new report by Grand View Research, Inc. The growth is majorly driven by factors such as rising demand for minerals, increasing quarrying activities, and water treatment.

The penetration of the product in explosives & drilling applications is considerable due to an increase in mining activities across the globe. Africa has an abundance of natural resources such as gold, diamond, phosphate, copper, iron ore, and many others. Explosives and drilling processes are used to extract minerals from deep earth. The increase in mining activities is likely to boost the growth of the product globally over the forecast period.

The rising demand for different minerals, especially gold, across regions has resulted in a hike in mining activities, which is likely to boost the product over the forecast period. The demand for gold is increasing every year in India, China, the U.S., Saudi Arabia, the UAE, Turkey, Russia, and Egypt, which are its leading consumers. Gold is majorly used for manufacturing jewelry. As of 2020, India and China together account for 57% of the total consumption of gold globally.

Increasing foreign investments in emerging countries of Asia Pacific, including India and China, have contributed to the growth of the mining chemicals in the region. India has an abundance of natural reserves of coal, bauxite, titanium, diamond, and limestone. The growing quarrying and mineral processing activities in the country are projected to promote the utilization of mining chemicals in the region over the forecast period.

Key manufacturers in the industry are focused on expanding the production of their major product portfolios, including high-grade mining chemicals, to gain higher shares. The invention of new technological advancements in chemical mining has led to the development of environmentally friendly products by admiring of sustainable manufacturing processes for production. Arkema, Sasol, and BASE SE are some of the players in the industry that supply raw materials for the production of sustainable products.

Request a free sample copy or view report summary: Mining Chemicals Market Report

Mining Chemicals Market Report Highlights

• The Asia Pacific region witnessed the fastest growth rate of 7.0% in terms of revenue from 2024 to 2030. This is attributable to the increasing mining activities in major economies such as India and China
• Based on ore type, Iron ore is expected to grow at a faster growth rate of 6.8% in terms of revenue from 2024 to 2030. The demand for high-grade iron ore is expected to rise over the forecast period due to increasing demand for iron with fewer impurities from the steel industry.
• Gold ore is expected to witness a substantial growth rate of 6.4% after iron ore in terms of revenue from 2024 to 2030, owing to its utilization in different applications, including medicine, water treatment, printing paper, and making colors for painting.
• In terms of application, the explosives & drilling segment accounted for the largest share of 35.6% of the total market volume in 2023. This high share is attributable to the growing demand for minerals and metal leads, as explosives & drilling are majorly used in opencast mining operations.
• Compliance with the regulations is a major concern for the industry players. Sustainable production and distribution of products are achieved by following the required norms. For instance, the European Commission and EPA are key authorities governing the regulations for the European region, which are binding for every manufacturer in the region.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mining-chemicals-market

Mining Chemicals Market Segmentation

Grand View Research has segmented the global mining chemicals market report based on ore type, application, and region:

Mining Chemicals Ore Type Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)

• Powder Gold Ore Type
  • Collectors
  • Coatings
  • Flocculants
  • Grinding Aids
  • Solvent Extractants
  • Dust Suppressants
  • Defoamers
  • Antiscalants
  • Biocides
  • Lubricants
  • Frothers
  • Others
• Iron Ore Type
  • Collectors
  • Coatings
  • Flocculants
  • Grinding Aids
  • Solvent Extractants
  • Dust Suppressants
  • Defoamers
  • Antiscalants
  • Biocides
  • Lubricants
  • Frothers
  • Others
• Copper Ore Type
  • Collectors
  • Coatings
  • Flocculants
  • Grinding Aids
  • Solvent Extractants
  • Dust Suppressants
  • Defoamers
  • Antiscalants
  • Biocides
  • Lubricants
  • Frothers
  • Others
• Phosphate Ore Type
  • Collectors
  • Coatings
  • Flocculants
  • Grinding Aids
  • Solvent Extractants
  • Dust Suppressants
  • Defoamers
  • Antiscalants
  • Biocides
  • Lubricants
  • Frothers
  • Others
• Others Ore Type
  • Collectors
  • Coatings
  • Flocculants
  • Grinding Aids
  • Solvent Extractants
  • Dust Suppressants
  • Defoamers
  • Antiscalants
  • Biocides
  • Lubricants
  • Frothers
  • Others

Mining Chemicals Application Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)

• Mineral Processing
• Explosives and Drilling
• Water Treatment
• Others

Mining Chemicals Regional Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
  • Peru
  • Chile
  • Columbia
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Ghana
  • Morocco
  • DRC
  • Zambia
  • Zimbabwe
  • Tanzania
  • Mali
  • Ivory Coast
  • Sudan

List of Key Players in the Mining Chemicals Market

• AECI Mining Chemicals
• BASF SE
• Ashland
• Dow
• Kimleigh Chemicals SA (Pty) Ltd (PTY) LTD
• Cytec Solvay Group
• Arkema
• Clariant
• Nowata
• Kemira
• Shell Chemicals
• Quaker Chemical Corporation
• Akzo Nobel N.V.
• Solenis
• Sasol

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Magnetoencephalography Market is Expected to Enhance $432.56 Million Revenue By 2030: Grand View Research Inc.

 Magnetoencephalography Market Growth & Trends

The global magnetoencephalography market size is expected to reach USD 432.56 million by 2030, expanding at a CAGR of 5.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing frequency of new product launches and the rise in the incidence of neurological disorders such as epilepsy, and stroke are key drivers to market growth. In addition, the growing geriatric population is also expected to drive market growth since they are more prone to neurodegenerative diseases. According to the World Health Organization, neurological disorders are a leading cause of death, accounting for 12% of all deaths worldwide.

MEG technologies detect the weak magnetic fields created in the brain and use them to quantify brain functionality and map brain activity. In a clinical setting, MEG provides a number of inherent applications. Scans can be performed in a safe and silent atmosphere due to the passive nature of the recordings, which even allows a patient's companion to be present within the shielded area.

Technological developments are likely to contribute to market expansion, such as the introduction of whole-head systems and developments in computer technology, MEG has evolved significantly in the last two decades. Whenever a precise and high degree of localization is required, MEG is now the imaging modality of choice. Furthermore, magnetoencephalography (MEG), is an invaluable tool that is used by researchers to study the connections and dynamics of large-scale brain activity.

The market's prominent competitors are acquiring medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, the University of Nottingham has partnered with Magnetic Shields Limited (MSL) of Kent to develop Cerca Magnetics Limited, a new spin-out company that will deliver the world's most advanced functional wearable brain scanner to market. It is designed to let people move around freely while being scanned. 

Request a free sample copy or view report summary: Magnetoencephalography Market Report

Magnetoencephalography Market Report Highlights

• By application, the clinical segment dominated the market in 2023 and is further expected to grow at the fastest CAGR of about 6.0% over the forecast period.
• The clinical segment is further sub-segmented into dementia, autism, schizophrenia, multiple sclerosis, stroke, epilepsy, and others, in which the epilepsy sub-segment held the largest market share owing to its increasing prevalence worldwide
• In terms of end use, the hospital segment held the largest share in 2023, owing to the increasing number of hospitals in developing countries and growing competition among healthcare service providers
• The imaging center segment is expected to experience the fastest growth rate during the forecast period due to its convenience, proximity, and lower costs to patients and insurers
• Asia Pacific is anticipated to be growing at the fastest CAGR during the forecast period due to the presence of untapped opportunities in the emerging economies in China and India

Access Press Release@ https://www.grandviewresearch.com/press-release/global-magnetoencephalography-market

Magnetoencephalography Market Segmentation

Grand View Research has segmented the global magnetoencephalography market based on application, end-use, and region:

Magnetoencephalography Application Outlook (Revenue, USD Million, 2018 - 2030­)

• Clinical
  • Dementia
  • Autism
  • Schizophrenia
  • Multiple Sclerosis
  • Stroke
  • Epilepsy
  • Others
• Research

Magnetoencephalography End Use Channel Outlook (Revenue, USD Million, 2018 - 2030­)

• Hospitals
• Imaging Ccenters
• Academic and Rresearch Iinstitutes

Magnetoencephalography Regional Outlook (Revenue, USD Million, 2018 - 2030­)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Magnetoencephalography Market

• Compumedics Limited
• MEGIN
• Ricoh
• CTF MEG NEURO INNOVATIONS, INC.
• FieldLine Inc.
• Cerca Magnetics Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Buccal Drug Delivery Systems Market Is Expected To Gain Significant Traction Over The Forecast Period: Grand View Research Inc.

 Buccal Drug Delivery Systems Market Growth & Trends

The global buccal drug delivery systems market size is expected to reach USD 6.56 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.2% from 2024 to 2030. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.

Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022.

Request a free sample copy or view report summary: Buccal Drug Delivery Systems Market Report

Buccal Drug Delivery Systems Market Report Highlights

• The buccal tablets and lozenges type segment accounted for the largest revenue share in 2023 due to its wider acceptance among patients
• The smoking cessation application segment held the largest share in 2023. Buccal drug delivery is often the most preferred and effective formulation for treating patients with smoking or nicotine addiction
• The hospital end-user segment captured the largest revenue share in 2023 owing to a large number of admissions of geriatric patients and abundant medication supplies
• North America held the largest revenue share in 2023 due to a large number of leading manufacturers and growing research in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-buccal-drug-delivery-systems-market

Buccal Drug Delivery Systems Market Segmentation

Grand View Research has segmented the global buccal drug delivery systems market on the basis of type, application, end-user, and region:

Buccal Drug Delivery Systems Type Outlook (Revenue, USD Million, 2018 - 2030)

• Sublingual Films and Wafers
• Buccal Tablets/Lozenges
• Oral Sprays

Buccal Drug Delivery Systems Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pain Management
• Smoking Cessation
• Angina Pectoris
• Others

Buccal Drug Delivery Systems End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Centers
• Others (Clinics, Home Health/OTC)

Buccal Drug Delivery Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List Of Key Players in the Buccal Drug Delivery Systems Market

• GSK plc
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Generex Biotechnology Corporation (LUMITOS AG)
• ARx, LLC.
• Endo, Inc.
• Catalent, Inc
• Cynapsus Therapeutics Inc.
• Collegium Pharmaceutical
• Indivior PLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

T-cell Lymphoma Market is Anticipated To Generate Significant Revenues by 2030: Grand View Research Inc.

 T-cell Lymphoma Market Growth & Trends

The global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The TCL market is expanding substantially, driven by advancements in treatment options and strategic initiatives by pharmaceutical companies. The introduction of 14 new pipeline agents and expanded therapies for new indications are key factors fueling this growth. These developments aim to provide patients with more treatment choices beyond traditional chemotherapy, which has been a cornerstone in TCL therapy.

In 2023, the U.S. reported around 12,600 new cases of Peripheral T-Cell Lymphoma (PTCL), a number expected to rise by 2030, reflecting an increasing disease incidence. Moreover, CAR-T therapies for Non-Hodgkin Lymphoma (NHL) in markets such as the United States, France, Germany, Italy, Spain, UK, and Japan totaled approximately 155,300 cases in 2023. The pipeline for CAR-T therapies is diverse, targeting various stages of development and focusing mainly on B-cell Lymphoma types, with emerging interest in PTCL treatments.

Currently, anthracycline-based chemotherapy remains standard for newly diagnosed PTCL patients, with regimens like CHOP or CHOEP being typical first-line treatments. However, newer approaches such as CHP-BV for ALCL illustrate a shift towards more targeted therapies, enhancing treatment efficacy. Additionally, Japan has seen significant advancements with the introduction of drugs like HIYASTA, DARVIAS, and REMITORO for ATLL and R/R PTCL, expanding treatment options and driving market growth. These innovations provide hope for better outcomes, particularly for patients with limited therapeutic choices.

The field of CAR-T and NK cell therapies is also progressing, moving from preclinical phases to larger clinical studies. These innovative approaches offer promising prospects for personalized TCL treatments. In addition, biologics targeting specific TCL-related proteins and signals are under development, including PD-1/PD-L1 inhibitors, NK-cell engagers, anti-CD47 antibodies, and drugs like mogamulizumab targeting CCR4. These advancements aim to create more precise treatment platforms, potentially improving patient outcomes.

Looking ahead, strategic initiatives by pharmaceutical companies are expected to drive significant market changes by 2030, particularly in Japan and the U.S. These initiatives include introducing established drugs into new markets, exploring novel treatment approaches, and focusing on under-researched targets tailored to TCL subtypes.

However, the market faces challenges such as patent expires on standard treatments, leading to generic competition that could impact sales. Nonetheless, the entry of new agents into the market is anticipated to mitigate these challenges and sustain growth momentum.

Key players like Takeda Pharmaceuticals, Bristol-Myers Squibb, and Novartis are pivotal in driving market dynamics, alongside emerging firms such as Citius Pharmaceuticals, Innate Pharma, and Soligenix. Their innovative therapies like ADCETRIS and POTELIGEO are crucial in meeting TCL treatment needs. Novartis's commitment to CAR-T therapies underscores ongoing innovation, while emerging treatments like I/ONTAK (E7777), SGX301, and Lacutamab are poised to further enrich TCL management strategies. These companies are pivotal in shaping the future TCL landscape through strategic initiatives and pioneering treatments.

Request a free sample copy or view report summary: T-cell Lymphoma Market Report

T-cell Lymphoma Market Report Highlights

• Based on type, the Peripheral T-Cell Lymphoma (PTCL) segment held the largest revenue share of 66.47% in 2023
• Based on therapy, the chemotherapy segment held the largest revenue share of 26.69% in 2023. For many years, chemotherapy has been the cornerstone of TCL treatment, with regimens such as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) and CHOEP (cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone) being commonly used. These regimens are widely recognized for their effectiveness in managing disease and are typically the first line of treatment for newly diagnosed patients
• The Immunotherapy segment is expected to grow with a fastest growth rate of 7.21% over the forecast period. This rapid growth is driven by significant advancements and the introduction of novel therapies that harness the body's immune system to target cancer cells more precisely
• North America represents the largest market with share of 37.67% in 2023, driven by advanced healthcare infrastructure, high healthcare expenditure, and significant ongoing research and development

Access Press Release@ https://www.grandviewresearch.com/press-release/global-t-cell-lymphoma-market

T-Cell Lymphoma Market Segmentation

Grand View Research has segmented the global T-Cell lymphoma market based on type, therapy, and region:

T-Cell Lymphoma Type Outlook (Revenue, USD Million, 2018 - 2030)

• Peripheral
  • Cutaneous T-cell Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Angio-immuno-blastic T-cell Lymphoma
  • Other
• Lymphoblastic

T-Cell Lymphoma Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Radiotherapy
• Chemotherapy
• Immunotherapy
• Stem Cell Transplantation
• Other

T-Cell Lymphoma Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the T-cell Lymphoma Market

• Acrotech Biopharma
• Affimed GmbH
• Bristol Myers Squibb
• Chipscreen Biosciences
• Citius Pharma
• Daiichi Sankyo Company, Limited
• Eisai Co., Ltd.
• Genor Biopharma Co. Ltd
• Innate Pharma
• Dizal Pharma

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Impression System Market will be Worth $3.19 Billion by 2030: Grand View Research Inc.

 Dental Impression System Market Growth & Trends

The global dental impression system market size is expected to reach USD 3.19 billion by 2030, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to several key factors. The rising demand for cosmetic dental procedures, such as teeth whitening, veneers, and dental implants, is a major driver for the market growth. As individuals become increasingly conscious of their appearance and seek to enhance their smiles, the need for accurate dental impressions to create customized restorations has increased.   

Moreover, the growing prevalence of dental diseases, including dental caries, periodontal diseases, and tooth loss, is another significant factor contributing to the expansion of the market. As more people seek treatment for these conditions, the demand for accurate dental impressions to create prosthetics, crowns, and other restorative solutions has risen. According to the World Health Organization 2023 report, nearly 3.5 billion people globally suffered from oral diseases, highlighting the substantial market potential for dental impression systems.

Furthermore, the adoption of digital dentistry technologies, such as intraoral scanners and CAD/CAM systems, has revolutionized the dental impression process. These advanced systems offer increased accuracy, efficiency, and patient comfort compared to traditional impression techniques, driving their widespread adoption in the industry. In 2023, a leading dental technology company, Dentsply Sirona, launched its latest intraoral scanner, the CEREC Primescan, which features improved scanning speed and accuracy, further boosting the demand for digital dental impression systems. As these technologies continue to advance and become more accessible, they are expected to play a significant role in shaping the future of the dental impression system market.

Request a free sample copy or view report summary: Dental Impression System Market Report

Dental Impression System Market Report Highlights

• Based on product, the impression materials segment dominated the market and held the largest revenue share of over 44.39% in 2023. This is primarily due to their widespread use in various dental procedures, including crowns, bridges, and dentures, where they provide excellent precision and detail for accurate dental impressions
• Based on application, the restorative & prosthodontics dentistry segment dominated the market and held the largest revenue share of over 60.97% in 2023 due to the growing edentulous population and the increasing demand for dental restorations and prosthetics. The segment's dominance is also attributed to the high prevalence of dental diseases and the rising need for cosmetic dentistry
• Based on end-use, the dental clinics segment dominated the market with a revenue share of over 56.0% in 2023, and is expected to grow at the fastest CAGR of 10.0% from 2024 to 2030 due to the rising incidence of dental diseases and the growing need for advanced dental treatments. The segment's dominance is also attributed to the increasing adoption of digital impression systems in dental clinics, which enhance the accuracy and efficiency of dental procedures
• In 2023, Europe led the market with a share of 40.39%, due to the high prevalence of dental diseases and a growing demand for cosmetic dentistry. Additionally, the presence of key market players and ongoing research and development activities further fueled the market growth in Europe

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dental-impression-system-market

Dental Impression System Market Segmentation

Grand View Research has segmented the global dental impression system market based on product, application, end-use and region:

Dental Impression System Product Outlook (Revenue, USD Million, 2018 - 2030)

• Impression Materials
• Intraoral Scanners
• Impression Trays
• Others

Dental Impression System Application Outlook (Revenue, USD Million, 2018 - 2030)

• Restorative & Prosthodontics Dentistry
• Orthodontics

Dental Impression System End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Dental Clinics
• Others

Dental Impression System Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Dental Impression System Market

• 3M Company
• Dentsply Sirona
• Henry Schein Inc.
• Mitsui Chemicals (Kulzer GmbH)
• Envista (Kerr Corporation)
• 3Shape
• Ivoclar Vivadent 
• Coltene Group
• Ultradent Products Inc.
• Septodont Holding.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.